A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat as Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared With Co-administration of the Separate Agents
Clinical trial NCT04661397 · COMPLETED
Trial details
- NCT number
- NCT04661397
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-05
- Primary completion
- 2021-07-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.